Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
Open | $70.30 |
Close | $69.13 |
Volume / Avg. | 2.12M / 2.24M |
Day Range | $69.00 - $70.92 |
52 Wk Range | 68.83 - 99.56 |
Market Cap | $13.18B |
P/E Ratio | 53.55 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 3.09% |
Days to Cover | 4.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
Biomarin Pharmaceutical has a consensus price target of $104.08.
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $69.2375 last updated September 23, 2024 at 5:55 PM EDT.
There are no upcoming dividends for Biomarin Pharmaceutical.
Biomarin Pharmaceutical’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Biomarin Pharmaceutical.
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.